Having had setbacks with torcetrapib and Exubera, and with generic competition to Norvasc and Lipitor, Pfizer is putting more emphasis into animal drugs.
Pfizer: Going to the dogs
More in Uncategorized
Past Week
Past 6 Months
-
Medicine’s struggle for inclusivity
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Elite access vs. public scrutiny: Medication disparities exposed
-
How Enhanced Recovery After Surgery solves our opioid problems
-
Real pain deserves real treatment
-
Recent Posts
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
